Trials / Completed
CompletedNCT05730010
Discerning the Impact of ctDNA Detection on Patient Decision Making in Early Stage Breast Cancer: a Conjoint Analysis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 289 (actual)
- Sponsor
- Indiana University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will examine how ctDNA and additional prognostic genomic information in patients with early stage breast cancer might influences patient decision- making regarding systemic therapy options.
Detailed description
This study is an electronically delivered, one time cross sectional survey study. The investigators want to understand how patients with triple negative breast cancer at high risk for disease recurrence will prioritize additional benefit over toxicity when considering treatment options, and if their knowledge of ctDNA positivity versus negativity will further shift this balance toward benefit.
Conditions
Timeline
- Start date
- 2023-04-16
- Primary completion
- 2023-06-26
- Completion
- 2023-06-26
- First posted
- 2023-02-15
- Last updated
- 2023-08-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05730010. Inclusion in this directory is not an endorsement.